Effect of the recall software Impfdoc on vaccination rates among paediatricians
| ISRCTN | ISRCTN75503825 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN75503825 |
| Secondary identifying numbers | N/A |
- Submission date
- 16/04/2008
- Registration date
- 16/05/2008
- Last edited
- 02/10/2008
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Infections and Infestations
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year
Plain English summary of protocol
Not provided at time of registration
Contact information
Prof Rüdiger von Kries
Scientific
Scientific
Institut für Soziale Pädiatrie und Jugendmedizin
Heiglhofstr. 63
Munich
81377
Germany
Study information
| Study design | Cluster-randomised controlled trial. |
|---|---|
| Primary study design | Interventional |
| Secondary study design | Randomised controlled trial |
| Study setting(s) | Not specified |
| Study type | Not Specified |
| Scientific title | |
| Study acronym | EERSV |
| Study objectives | Children who are treated by paediatricians who use the recall software Impfdoc have higher vaccination rates than those treated by paediatricians not using the software. |
| Ethics approval(s) | Ethics Board of the Medical faculty, University of Munich. Approved on 04/04/2008 (Project no. 035-08) |
| Health condition(s) or problem(s) studied | Vaccination rates |
| Intervention | Paediatricians are offered the software Impfdoc and an instruction for the software free of charge. One group receives the software earlier (intervention group) and one group later (control group). The delay in the distribution of the software depends on the organisation of the instructions. The control group is expected to receive the software 3-6 months later. |
| Intervention type | Other |
| Primary outcome measure | Proportion of children who received full immunisation until the age of 12 months according to the recommendations of the German standing committee on vaccinations (Ständige Impfkommission STIKO). |
| Secondary outcome measures | Proportion of children who have received their second dose of measles vaccination, assessed at the age of 2 years. |
| Overall study start date | 01/08/2008 |
| Completion date | 31/12/2010 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Child |
| Sex | Both |
| Target number of participants | 200 paediatricians, 1600 children. |
| Key inclusion criteria | Paediatricians in Bavaria, Germany, and children treated by these paediatricians. |
| Key exclusion criteria | Children switching paediatricians (only if paediatricians are not in same study group) within the study period. |
| Date of first enrolment | 01/08/2008 |
| Date of final enrolment | 31/12/2010 |
Locations
Countries of recruitment
- Germany
Study participating centre
Institut für Soziale Pädiatrie und Jugendmedizin
Munich
81377
Germany
81377
Germany
Sponsor information
Individual sponsor (Germany)
Other
Other
Dr. med. Hans-Jürgen Schrörs
Institut für Medizinische Information
Oberau 79
Freiburg
79102
Germany
| Phone | +49 761 70700 34/ 23 |
|---|---|
| hj.schroers@inst4med.de |
Funders
Funder type
Industry
Institute for Medical Information (Institut für medizinische Information) (Germany)
No information available
Results and Publications
| Intention to publish date | |
|---|---|
| Individual participant data (IPD) Intention to share | No |
| IPD sharing plan summary | Not provided at time of registration |
| Publication and dissemination plan | Not provided at time of registration |
| IPD sharing plan |
